Circ-GALNT16 restrains colorectal cancer progression by enhancing the SUMOylation of hnRNPK

Table 1 Relevance analysis of circ-GALNT16 expression in CRC patients (n = 100)

Variables	All patients	circ-GALNT16		P value
Variables	All patients	Low	High	P value
All Cases	100	50	50
Age (years)
<60	35	16	19	0.53
≥60	65	34	31	0.53
Gender
Female	41	18	23	0.31
Male	59	32	27	0.31
Tumor size (cm)
<5	55	19	36	0.001
≥5	45	31	14	0.001
Tumor stage
Stage I+II	59	22	37	0.002
Stage III+IV	41	28	13	0.002
Lymph node metastasis
No	61	23	38	0.002
Yes	39	27	12	0.002
Distant metastasis
No	93	47	46	>0.99
Yes	7	3	4	>0.99
CEA (ng/ml)
<4.70	46	25	21	0.42
≥4.70	54	25	29	0.42

NOTE: CEA carcinoembryonic antigen
All data are presented as the means ± SD of three independent experiments. P ≤ 0.05 was considered significant. The bold type represents P values smaller than 0.05

ISSN: 1756-9966